| A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants LG Fritsche, W Igl, JNC Bailey, F Grassmann, S Sengupta, ... Nature genetics 48 (2), 134-143, 2016 | 1785 | 2016 |
| Seven new loci associated with age-related macular degeneration Nature genetics 45 (4), 433-439, 2013 | 925 | 2013 |
| Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration W Chen, D Stambolian, AO Edwards, KE Branham, M Othman, ... Proceedings of the National Academy of Sciences 107 (16), 7401-7406, 2010 | 635 | 2010 |
| Advanced glycation end products increase retinal vascular endothelial growth factor expression. M Lu, M Kuroki, S Amano, M Tolentino, K Keough, I Kim, R Bucala, ... The Journal of clinical investigation 101 (6), 1219-1224, 1998 | 605 | 1998 |
| Diffusion of high molecular weight compounds through sclera J Ambati, CS Canakis, JW Miller, ES Gragoudas, A Edwards, ... Investigative ophthalmology & visual science 41 (5), 1181-1185, 2000 | 562 | 2000 |
| Risk of inflammation, retinal vasculitis, and retinal occlusion–related events with brolucizumab: post hoc review of HAWK and HARRIER J Monés, SK Srivastava, GJ Jaffe, R Tadayoni, TA Albini, PK Kaiser, ... Ophthalmology 128 (7), 1050-1059, 2021 | 401 | 2021 |
| Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes I Kim, AM Ryan, R Rohan, S Amano, S Agular, JW Miller, AP Adamis Investigative ophthalmology & visual science 40 (9), 2115-2121, 1999 | 327 | 1999 |
| Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families CNJ Njauw, I Kim, A Piris, M Gabree, M Taylor, AM Lane, MM DeAngelis, ... PloS one 7 (4), e35295, 2012 | 304 | 2012 |
| Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide S Walpole, AL Pritchard, CM Cebulla, R Pilarski, M Stautberg, ... JNCI: Journal of the National Cancer Institute 110 (12), 1328-1341, 2018 | 292 | 2018 |
| Pseudophakic cystoid macular edema Y Yonekawa, IK Kim Current opinion in ophthalmology 23 (1), 26-32, 2012 | 287 | 2012 |
| Progression of geographic atrophy in age-related macular degeneration: AREDS2 report number 16 TD Keenan, E Agrón, A Domalpally, TE Clemons, F van Asten, WT Wong, ... Ophthalmology 125 (12), 1913-1928, 2018 | 248 | 2018 |
| Conversion to aflibercept for chronic refractory or recurrent neovascular age-related macular degeneration Y Yonekawa, C Andreoli, JB Miller, JI Loewenstein, L Sobrin, D Eliott, ... American journal of ophthalmology 156 (1), 29-35. e2, 2013 | 224 | 2013 |
| Subretinal hyperreflective material in the comparison of age-related macular degeneration treatments trials AS Willoughby, G Ying, CA Toth, MG Maguire, RE Burns, JE Grunwald, ... Ophthalmology 122 (9), 1846-1853. e5, 2015 | 218 | 2015 |
| Genetics of age-related macular degeneration (AMD) MM DeAngelis, LA Owen, MA Morrison, DJ Morgan, M Li, A Shakoor, ... Human molecular genetics 26 (R1), R45-R50, 2017 | 213 | 2017 |
| Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT) SA Hagstrom, G Ying, GJT Pauer, GM Sturgill-Short, J Huang, ... Ophthalmology 120 (3), 593-599, 2013 | 204 | 2013 |
| Identification of a rare coding variant in complement 3 associated with age-related macular degeneration X Zhan, DE Larson, C Wang, DC Koboldt, YV Sergeev, RS Fulton, ... Nature genetics 45 (11), 1375-1379, 2013 | 199 | 2013 |
| Age-related macular degeneration: advances in management and diagnosis Y Yonekawa, JW Miller, IK Kim Journal of clinical medicine 4 (2), 343-359, 2015 | 190 | 2015 |
| Long-term outcomes of adding lutein/zeaxanthin and ω-3 fatty acids to the AREDS supplements on age-related macular degeneration progression: AREDS2 report 28 EY Chew, TE Clemons, E Agrón, A Domalpally, TDL Keenan, S Vitale, ... JAMA ophthalmology 140 (7), 692-698, 2022 | 185 | 2022 |
| Survival rates in patients after treatment for metastasis from uveal melanoma AM Lane, IK Kim, ES Gragoudas JAMA ophthalmology 136 (9), 981-986, 2018 | 168 | 2018 |
| Regression of some high-risk features of age-related macular degeneration (AMD) in patients receiving intensive statin treatment DG Vavvas, AB Daniels, ZG Kapsala, JW Goldfarb, E Ganotakis, ... EBioMedicine 5, 198-203, 2016 | 167 | 2016 |
